Results 111 to 120 of about 17,680 (157)

Phase 2 study of futibatinib in combination with pembrolizumab in patients with FGF19 expressing advanced hepatocellular carcinoma. [PDF]

Oncologist
Tran NH, Palmer ME, Ulrich A, McCue SA, Mahipal A, Ma WW, Babiker HM, Majeed U, Halfdanarson TR, McWilliams RR, Jin Z, Carr R, Kankeu Fonkoua LA, Washburn L, Conboy C, Graham RP, Torbenson M, Starlinger P, Jethwa KR, Hallemeier C, Revzin A, Thompson SM, Goenka AH, Venkatesh SK, Sonbol MB, Borad MJ, Bekaii-Saab T, Gores GJ, Roberts LR, Heimbach JK, Ou FS.   +30 more
europepmc   +1 more source

Reinventing chemotherapy. [PDF]

Oncologist
Chabner BA, Gehri J, Thompson BB.
europepmc   +1 more source

SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of esophageal cancer (update 2025). [PDF]

Clin Transl Oncol
Fernández-Montes A, Alcaide J, Custodio AB, Fernández Franco L, Gallego Plazas J, Gómez-Martín C, Richart P, Rivera F, Alsina M.   +8 more
europepmc   +1 more source

Machine learning identifies a distinct microbiota signature in immune checkpoint inhibitor colitis compared with inflammatory bowel disease. [PDF]

Oncologist
Barberio B, Patuzzi I, Bertin L, Facchin S, De Ruvo M, Bonazzi E, De Barba C, Dal Maso A, Frega S, Simionati B, Sattin E, Buda A, Zingone F, Burra P, Dei Tos AP, Pasello G, Bonanno L, Savarino EV.   +17 more
europepmc   +1 more source

Vorwort

Zeitschrift für Rezensionen zur Germanistischen Sprachwissenschaft, 2015
doaj   +1 more source

Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinoma. [PDF]

Oncologist
Lee MS, Chao J, Mulcahy MF, Kasi PM, Alistar AT, Mukherjee S, Akce M, Moore DT, McRee AJ, Somasundaram A.   +9 more
europepmc   +1 more source

Less frequent intravenous dosing of nemvaleukin alfa in patients with advanced solid tumors: the phase 1/2 ARTISTRY-3 trial. [PDF]

Oncologist
Piha-Paul SA, Call JA, Spira AI, Bartolomé J, de Miguel M, Chen X, Donatelli SS, Lakhani NJ.   +7 more
europepmc   +1 more source

Efficacy of neoadjuvant endocrine therapy with CDK4/6 inhibitors in locally advanced breast cancer. [PDF]

Oncologist
Zhang M, Li M, Zhou S, Jiang M, Liu J, Yang X, Qin L, Abudureheiyimu N, Shi X, Li L, Li F, Guan X, Ma F, Xu B, Li Q.   +14 more
europepmc   +1 more source